• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Latest News about LILLY DRN

Recent news which mentions LILLY DRN

< Previous 1 2 3 Next >
Eli Lilly to release late-stage data on next-generation weight loss drug retatrutide in 2025, earlier than expected
February 06, 2025
Tags Companies Business Science
From CNBC.com News
Eli Lilly posts mixed quarter even as demand for weight loss, diabetes drugs soars
February 06, 2025
Tags Health & Science LILLY DRN US: News
From CNBC.com News
Novo Nordisk CEO says he's confident about Wegovy supply, next-generation weight loss drugs
February 05, 2025
Tags Health care industry Health & Science LILLY DRN
From CNBC.com News
Novo Nordisk posts net profit beat as Wegovy sales jump 107% in fourth quarter
February 05, 2025
Tags Business Pharmaceuticals Breaking News: Europe
From CNBC.com News
Healthy Returns: Why people quit weight loss, diabetes drugs within one year
February 04, 2025
Tags LILLY DRN Social issues Health care industry
From CNBC.com News
5 things to know before the stock market opens Monday
February 03, 2025
Tags Markets Walt Disney Co Palantir Technologies Inc
From CNBC.com News
Reid Hoffman enters 'wondrous and terrifying' world of health care with latest AI startup
February 02, 2025
Tags Merck & Co Inc Health care industry Pfizer Inc
From CNBC.com News
Jim Cramer's week ahead: Earnings from Amazon, Alphabet, Eli Lilly, Palantir
January 31, 2025
Tags Business News Pfizer Inc Alphabet Inc
From CNBC.com News
FDA approves Novo Nordisk’s diabetes drug Ozempic for chronic kidney disease, expanding its use
January 28, 2025
Tags US: News LILLY DRN Health & Science
From CNBC.com News
Food-as-medicine startups hope Kennedy, if confirmed as HHS secretary, will boost their businesses
January 28, 2025
Tags Medicaid Novo Nordisk A/S Medicare
From CNBC.com News
Pharma is hopeful about Trump's second term — here's what to expect for drugmakers
January 26, 2025
Tags Business News Biotech and Pharmaceuticals Pfizer Inc
From CNBC.com News
'Miracle' drug innovation could see a new Wegovy launch every couple of years, Larry Summer says
January 21, 2025
Tags Davos WEF Biotech and Pharmaceuticals World economy
From CNBC.com News
GLP-1s and Brian Thompson’s killing loom large at top health-care conference
January 18, 2025
Tags Health care industry Illumina Inc Amazon/com Inc
From CNBC.com News
Ozempic is in the next round of Medicare drug price negotiations. See the full list of 15 medications
January 17, 2025
Tags Teva Pharmaceutical Industries Ltd Biotechnology Theravance Biopharma Inc
From CNBC.com News
Bristol Myers Squibb says Alzheimer's is the biggest market for new schizophrenia drug
January 15, 2025
Tags Business News Biotech and Pharmaceuticals Bristol/Myers Squibb Co
From CNBC.com News
Jim Cramer says he supports healthcare stocks for their long-term value
January 14, 2025
Tags Investment Strategy Stock Picks Stock markets
From CNBC.com News
Healthy Returns: From Eli Lilly to Amazon, here are the latest health-care deals
January 14, 2025
Tags Biotech and Pharmaceuticals Madrigal Pharmaceuticals Inc Healthy Returns
From CNBC.com News
Eli Lilly shares drop as drugmaker cuts revenue guidance on weight loss drug demand
January 14, 2025
Tags Business News Earnings Breaking News: Business
From CNBC.com News
Eli Lilly CEO expects new weight loss pill to be approved next year
January 13, 2025
Tags Biotech and Pharmaceuticals Breaking News: Business Novo Nordisk A/S
From CNBC.com News
High-cost weight loss drugs are sending employers to nutrition counseling in a boost for startups
January 10, 2025
Tags Novo Nordisk A/S Business News Labor economy
From CNBC.com News
Medicare can now cover Eli Lilly’s Zepbound for sleep apnea, CMS says
January 08, 2025
Tags Novo Nordisk A/S Business News Biotech and Pharmaceuticals
From CNBC.com News
Healthy Returns: The FDA approved fewer new drugs in 2024 — but some big ones hit the market
January 08, 2025
Tags Healthy Returns Pfizer Inc Madrigal Pharmaceuticals Inc
From CNBC.com News
Cramer's Lightning Round: Uber is a buy
January 02, 2025
Tags LILLY DRN S&P 500 Lazard Ltd
From CNBC.com News
FDA says the Zepbound shortage is over. Here’s what that means for compounding pharmacies, patients who used off-brand versions
December 24, 2024
Tags Pharmaceuticals Health care industry Business
From CNBC.com News
FDA approves Eli Lilly's weight loss drug Zepbound for sleep apnea, expanding use in U.S.
December 20, 2024
Tags Health & Science US: News LILLY DRN
From CNBC.com News
5 things to know before the stock market opens Friday
December 20, 2024
Tags Breaking News: Technology Markets Investing
From CNBC.com News
FDA says Eli Lilly's weight loss drug Zepbound is no longer in shortage
December 19, 2024
Tags Breaking News: Business Biotechnology Social issues
From CNBC.com News
Healthy Returns: A huge deal to boost Novo Nordisk's manufacturing is one step closer to closing
December 11, 2024
Tags Social issues LILLY DRN Roche Holding AG
From CNBC.com News
Ro to offer lower-price vials of weight loss drug Zepbound by teaming up with Eli Lilly
December 11, 2024
Tags Companies Business Pharmaceuticals
From CNBC.com News
The weight-loss drug boom has become one of the internet's biggest scams
December 08, 2024
Tags Novo Nordisk A/S Cyber Report Social media
From CNBC.com News
< Previous 1 2 3 Next >
FinancialContent
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap